FSA
Franklin Street Advisors Portfolio holdings
AUM
$1.61B
1-Year Return
24.37%
This Quarter Return
-13.99%
1 Year Return
+24.37%
3 Year Return
+112.05%
5 Year Return
+186.1%
10 Year Return
+475.68%
AUM
$687M
AUM Growth
-$159M
(-19%)
Cap. Flow
-$13.8M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
34.69%
Holding
173
New
7
Increased
34
Reduced
66
Closed
26
Top Buys
| 1 |
Clorox
CLX
|
$12.1M |
| 2 |
Accenture
ACN
|
$11M |
| 3 |
AbbVie
ABBV
|
$8.11M |
| 4 |
Cisco
CSCO
|
$8.01M |
| 5 |
Starbucks
SBUX
|
$7.96M |
Top Sells
| 1 |
Constellation Brands
STZ
|
$10.7M |
| 2 |
Marriott International Class A Common Stock
MAR
|
$9.65M |
| 3 |
Yum! Brands
YUM
|
$6.92M |
| 4 |
Caterpillar
CAT
|
$5.99M |
| 5 |
Chevron
CVX
|
$5.68M |
Sector Composition
| 1 | Technology | 23.38% |
| 2 | Healthcare | 16.04% |
| 3 | Financials | 14.89% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Communication Services | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
EOG Resources
EOG
$64.4B
| $324K | 0.05% |
9,024
-98,571
| -92% | -$3.54M |
|
102
Enbridge
ENB
$105B
| $319K | 0.05% |
10,954
-2,919
| -21% | -$85K |
|
103
Ecolab
ECL
$77.6B
| $310K | 0.05% |
1,992
-458
| -19% | -$71.3K |
|
|
RTN
104
DELISTED
Raytheon Company
RTN
| $303K | 0.04% |
2,307
-425
| -16% | -$55.8K |
|
105
Truist Financial
TFC
$60B
| $302K | 0.04% |
9,777
-11,499
| -54% | -$355K |
|
106
IQVIA
IQV
$31.9B
| $299K | 0.04% |
2,775
-48,449
| -95% | -$5.22M |
|
107
Philip Morris
PM
$251B
| $299K | 0.04% |
4,093
-2,667
| -39% | -$195K |
|
108
Incyte
INCY
$16.9B
| $293K | 0.04% |
4,000
| – | – |
|
109
Abbott
ABT
$231B
| $281K | 0.04% |
3,567
-13
| -0.4% | -$1.02K |
|
|
SBR
110
Sabine Royalty Trust
SBR
$1.08B
| $276K | 0.04% |
10,000
| – | – |
|
111
Qualcomm
QCOM
$172B
| $271K | 0.04% |
4,000
-243
| -6% | -$16.5K |
|
112
Mattel
MAT
$6.06B
| $264K | 0.04% |
30,000
| – | – |
|
113
Dow Inc
DOW
$17.4B
| $243K | 0.04% |
8,294
+233
| +3% | +$6.83K |
|
114
Northrop Grumman
NOC
$83.2B
| $242K | 0.04% |
800
| – | – |
|
115
Sangamo Therapeutics
SGMO
$165M
| $241K | 0.04% |
37,780
+25,000
| +196% | +$159K |
|
116
ScottsMiracle-Gro
SMG
$3.64B
| $230K | 0.03% |
2,250
-60
| -3% | -$6.13K |
|
117
Acadia Pharmaceuticals
ACAD
$4.26B
| $228K | 0.03% |
5,400
| – | – |
|
118
Kimberly-Clark
KMB
$43.1B
| $223K | 0.03% |
1,745
-65
| -4% | -$8.31K |
|
119
DuPont de Nemours
DD
$32.6B
| $211K | 0.03% |
6,176
| – | – |
|
120
General Motors
GM
$55.5B
| $206K | 0.03% |
9,911
+738
| +8% | +$15.3K |
|
121
Capital One
COF
$142B
| $204K | 0.03% |
4,037
-70
| -2% | -$3.54K |
|
122
Towne Bank
TOWN
$2.87B
| $196K | 0.03% |
10,859
| – | – |
|
123
Protagonist Therapeutics
PTGX
$3.77B
| $166K | 0.02% |
23,500
| – | – |
|
124
Spyre Therapeutics
SYRE
$1.03B
| $163K | 0.02% |
1,400
+200
| +17% | +$23.3K |
|
125
BioCryst Pharmaceuticals
BCRX
$1.74B
| $150K | 0.02% |
75,000
+25,000
| +50% | +$50K |
|